Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count. - Wikidata - thesis-toulmin - TriplyDB

Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.

Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.

http://www.wikidata.org/entity/Q33414241

about

Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia.Immunodiagnosis of platelet activation in immune thrombocytopenia through scFv antibodies cognate to activated IIb3 integrins Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients [New perspectives on the role of αIIbβ3 integrin in defective megakaryopoiesis].Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies Low-level light treatment ameliorates immune thrombocytopenia.Autoantibodies in immune thrombocytopenia affect the physiological interaction between megakaryocytes and bone marrow extracellular matrix proteins.FC gamma receptor polymorphisms in patients with immune thrombocytopenia.Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.Emerging Concepts in Immune Thrombocytopenia.

P2860

Q26741269-096E1411-55F8-44AA-A420-45DAE53180A8 Q33420441-E964C538-E0DF-467A-A1D4-A0332F0DC211 Q33420459-E985905C-BA4C-4CE4-93CE-CB2FD33989A8 Q33421982-B136C1F0-F782-4FBF-8B75-8871AEBA220E Q33425381-A12430EC-158E-4091-915F-E458D03ED74A Q33430809-36BF9ECF-0838-4310-82CA-9996ABB6A9BB Q33431011-0DD47A12-EC01-4651-B804-9F6FA4AB9815 Q33432920-8BCAB22A-1085-4E2E-8BC7-1255DF9B88EA Q33434374-B736840A-010E-4CDF-8A25-F44A9CB0106B Q33437208-DFB7E30F-9C33-4C6F-9EC4-A70B4DA864C2 Q47405299-0C3DFC61-D84B-4893-898D-9063A1DB653D Q48299475-AB51A2B7-1C64-4028-9921-95BF298940D5 Q53633458-E7C94C94-2B88-41A7-8D90-002F26CC042A Q54211951-C26EDF31-0DD5-4F54-9D37-97E21A841CFD

P2860

Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.

http://www.wikidata.org/entity/Q33414241

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Impaired proplatelet formation ...... g to decreased platelet count.

@ast

Impaired proplatelet formation ...... g to decreased platelet count.

@en

type

label

Impaired proplatelet formation ...... g to decreased platelet count.

@ast

Impaired proplatelet formation ...... g to decreased platelet count.

@en

prefLabel

Impaired proplatelet formation ...... g to decreased platelet count.

@ast

Impaired proplatelet formation ...... g to decreased platelet count.

@en

P1433

Q33414241-7D0B3427-079E-420F-83D6-337CDBA2F84E

P1476

Q33414241-4EC876E5-41C3-40D8-BD37-7D39807C949C

P2093

Q33414241-0E917180-586A-4787-AC10-41875A8D5F05

Q33414241-15F79326-C139-43D7-8E5A-DA72E7551855

Q33414241-1A9E2929-3147-4B94-AA76-B680E6158A2B

Q33414241-294A0611-7810-436B-AADB-D69EB3A1BB82

Q33414241-2D798EB4-9E52-47A7-854C-FDC05095FAD9

Q33414241-2F36D06B-5977-47A9-8F8B-FEA968E3E55C

Q33414241-34B46F09-ED60-4314-A6CD-F2E7A5C2A1E8

Q33414241-6AAD63FA-DCAD-4C23-8F4F-D12434CF6DDD

Q33414241-7C79EB18-EADC-4614-AFF3-9F3ED8989DB5

Q33414241-A02FB3A0-22DF-481D-A38F-5BF2F51BD886

P2860

Q33414241-0DB72EC1-8338-47BE-9C77-0BE53E12E6A2

Q33414241-0EDB37A0-EC5A-4290-8C3D-F81603DB81CC

Q33414241-4785D3C5-1CC9-46C2-9875-62394760C5AC

Q33414241-4BE6C3C0-2135-47E5-823A-95C000CF2F5B

Q33414241-5C61259D-C41A-4DF4-8A84-1CC8E5059E69

Q33414241-634F9BEF-9C89-43F5-BFD3-AC885D3435E8

Q33414241-6FF41871-39F6-4D28-9BEC-DE06302A3525

Q33414241-7309A120-80BC-4BE4-A6E4-915B350E924B

Q33414241-8915E6C1-8C2F-4BBE-913A-5445DC7BD482

Q33414241-9BA27171-061F-4362-B569-0BBBB42242FC

P304

Q33414241-26C9B3B7-FB16-4A10-9816-882C4E383B71

P31

Q33414241-DB876DC8-8AC8-416E-B8A5-C76FE5F5DBC0

P356

Q33414241-780C953D-3A68-4525-9369-80ECBFE501F8

P407

Q33414241-EB3A7EF3-D72A-41C0-B0B2-314CFCC27B44

P433

Q33414241-EB4B9DD9-5D53-480E-BE91-507ECA3673EA

P478

Q33414241-CA0688A0-AB5A-459A-9ECB-D907B77AD55F

P577

Q33414241-5DB59334-0E35-4ADD-B150-6C8126BA2AF0

P5875

Q33414241-D724C7B6-4939-4BDE-805E-BFA3AB86C69B

P698

Q33414241-763DD7A9-3D3F-4C22-96C6-DCFF78AAD525

P921

Q33414241-E9EC04A1-D2B7-4243-B2F5-3E3441CB9795

P356

P1433

British Journal of Haematology

P1476

Impaired proplatelet formation ...... g to decreased platelet count.

@en

P2093

Ana C Glembotsky

http://www.w3.org/2001/XMLSchema#string

Felisa C Molinas

http://www.w3.org/2001/XMLSchema#string

Geraldine Contrufo

http://www.w3.org/2001/XMLSchema#string

Luciana Ferrari

http://www.w3.org/2001/XMLSchema#string

Marta S Pierdominici

http://www.w3.org/2001/XMLSchema#string

Matías Grodzielski

http://www.w3.org/2001/XMLSchema#string

Nora P Goette

http://www.w3.org/2001/XMLSchema#string

Paola R Lev

http://www.w3.org/2001/XMLSchema#string

Paula G Heller

http://www.w3.org/2001/XMLSchema#string

Rosana F Marta

http://www.w3.org/2001/XMLSchema#string

P2860

Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome.

Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes.

Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura.

Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.

Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3.

A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano.

Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.

Critical role of Src-Syk-PLC{gamma}2 signaling in megakaryocyte migration and thrombopoiesis.

P304

854-864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.12832

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261141895

http://www.w3.org/2001/XMLSchema#string

P698

24673454

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia